INVO BioScience(INVO) - 2021 Q1 - Quarterly Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 INVO Bioscience, Inc. (Exact name of registrant as specified in its charter) | Nevada | 001-39701 | 20-4036208 | | --- | --- | --- | | (State or other jurisdiction | (Commission | (I.R.S. Employer ...